ScholarIQanswers from OpenAlex & ORCID
James B. Leverenz
ResearcherPublications, citations & collaboration network
James B. Leverenz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James B. Leverenz have?
ScholarIQindexed works
James B. Leverenz has 485 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James B. Leverenz have?
ScholarIQcitation count
James B. Leverenz has 40,981 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James B. Leverenz?
ScholarIQh-index
James B. Leverenz has an h-index of 99 in OpenAlex.
What is the i10-index of James B. Leverenz?
ScholarIQi10-index
James B. Leverenz has an i10-index of 255 in OpenAlex.
What is the ORCID of James B. Leverenz?
ScholarIQorcid
The ORCID for James B. Leverenz is on the source record.
What is the OpenAlex record for James B. Leverenz?
ScholarIQopenalex
The OpenAlex for James B. Leverenz is on the source record.
What are the most-cited papers on James B. Leverenz?
ScholarIQmost cited works
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson, Irina Alafuzoff, Eileen H. Bigio, Constantin Bouras, Heiko Braak, Nigel J. Cairns, Rudolph J. Castellani, Barbara J. Crain, Peter Davies, Kelly Del Tredici, Charles Duyckaerts, Matthew P. Frosch, Vahram Haroutunian, Patrick R. Hof, Christine M. Hulette, Bradley T. Hyman, Takeshi Iwatsubo, K. A. Jellinger, Gregory A. Jicha, Enikò Kövari, Walter A. Kukull, James B. Leverenz, Seth Love, Ian R. Mackenzie, David Mann, Eliezer Masliah, Ann C. McKee, Thomas J. Montine, John C. Morris, Julie A. Schneider, Joshua A. Sonnen, Dietmar Rudolf Thal, John Q. Trojanowski, Juan C. Troncoso, Thomas Wısnıewskı, Randall L. Woltjer, Thomas G. Beach
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Shirley Lasch, Andrew Siderowf, Dag Aarsland, Paolo Barone, David J. Burn, Lana M. Chahine, Jamie L. Eberling, Alberto J. Espay, Eric D. Foster, James B. Leverenz, Irene Litvan, Irene Hegeman Richard, Matthew D. Troyer, Keith A. Hawkins, the Parkinson's Progression Markers Initiative
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Peggy Taylor, Leslie M. Shaw, John Q. Trojanowski, Andy Singleton, Mark Frasier, Kenneth Marek, Douglas Galasko, For the Parkinson's Progression Marker Initiative, Parkinson's Progression Marker Initiative, Kenneth Marek, Danna Jennings, Shirley Lasch, Caroline M. Tanner, Tanya Simuni, Christopher S. Coffey, Karl Kieburtz, Renée Wilson, Werner Poewe, Brit Mollenhauer, Tatiana Foroud, Todd Sherer, Sohini Chowdhury, Mark Frasier, Catherine Kopil, Vanessa Arnedo, Alice Rudolph, Cynthia Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Chelsea Caspell, Liz Uribe, Eric D. Foster, Katherine B. Gloer, Jon Yankey, Arthur W. Toga, Karen Crawford, Paola Casalin, Giulia Malferrari, Brit Mollenhauer, Douglas Galasko, Andrew Singleton, Keith A. Hawkins, David Russell, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Matthew Stern, Lana M. Chahine, James B. Leverenz, Samuel Frank, Irene Richard, Klaus Seppi, Holly A. Shill, Hubert Fernandez, Daniela Berg, Isabel Wurster, Douglas Galasko, Zoltan Mari, David J. Brooks, Nicola Pavese, Paolo Barone, Stuart Isaacson, Alberto J. Espay, Dominic B. Rowe, Melanie Brandabur, James W. Tetrud, Grace Liang, Álex Iranzo, Eduardo Tolosa, Laura Leary, C Riordan, Linda Rees, Alicia Portillo, Art Lenahan, Karen Williams, Stephanie Guthrie, Ashlee Brooke Rawlins, Sherry Harlan, Christine Hunter, Baochan Tran, Abigail Darin, Carly Linder, Marne Baca, Heli Venkov, Cathi-Ann Thomas, Raymond James, Cheryl Deeley, Courtney Bishop, Fabienne Sprenger, Diana Willeke, Sanja Obradov, Jennifer Mule, Nancy Monahan, Katharina Gauss